Results 271 to 280 of about 473,693 (291)

The Case for Catch-Up Human Papillomavirus Vaccination in At-Risk Populations: Rural Communities and Survivors of Pediatric and Young Adult Cancers

Ca-A Cancer Journal for Clinicians, 2020
Allison Grimes, Alec J Kacew, Deanna Teoh   +2 more
exaly  

Reply to the Case for Catch-Up Human Papillomavirus Vaccination in At-Risk Populations: Rural Communities and Survivors of Pediatric and Young Adult Cancers

Ca-A Cancer Journal for Clinicians, 2020
Robert A Smith, Debbie Saslow, Elizabeth T H Fontham   +2 more
exaly  

[Superiority of homologous rabies vaccines].

Bulletin - Office international des epizooties, 1972
K N, Boutchnev, E A, Aissen, I L, Kvassov   +2 more
openaire   +1 more source

Heterologous ChAdOx1/BNT162b2 Vaccination Induces Stronger Immune Response Than Homologous ChAdOx1 Vaccination: The Pragmatic, Multi-Center, Three-Arm, Partially Randomized HEVACC Trial

EBioMedicine, 2022
Alessandro Sette, Wegene Borena, Jose Mateus   +2 more
exaly  

Human Papillomavirus Vaccination Guideline Update: American Cancer Society Guideline Endorsement

Ca-A Cancer Journal for Clinicians, 2016
Lacey Loomer, Robert A Smith, Debbie Saslow   +2 more
exaly  

[Apropos of the sensitivity of B.C.G. vaccine to homologous tuberculoprotein].

La Revue lyonnaise de medecine, 1968
V, Golli, D, Stavri
openaire   +1 more source

Human Papillomavirus Genotype Distributions Inform Screening and Vaccination Policy

Ca-A Cancer Journal for Clinicians, 2009
Mary Desmond Pinkowish, M D Pinkowish
exaly  

Vaccination for the Prevention of Human Papillomavirus Cancers

Ca-A Cancer Journal for Clinicians, 2020
exaly  

Pneumococcal protein homologs and fragments for vaccines

2004
KOENIG SCOTT, HEINRICHS JON, JOHNSON LESLIE S, ADAMOU JOHN E   +3 more
openaire   +1 more source

Factors Influencing the Protective Efficacy of a BCG Homologous Prime-Boost Vaccination Regime Against Tuberculosis

Vaccine, 2006
C G Mackintosh, J F T Griffin, C G Mackintosh   +2 more
exaly